Junction Location Identifier (JuLI): Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology

J Mol Diagn. 2020 Mar;22(3):304-318. doi: 10.1016/j.jmoldx.2019.10.015. Epub 2019 Dec 25.

Abstract

Accurate detection of genomic fusions by high-throughput sequencing in clinical samples with inadequate tumor purity and formalin-fixed, paraffin-embedded tissue is an essential task in precise oncology. We developed the fusion detection algorithm Junction Location Identifier (JuLI) for optimization of high-depth clinical sequencing. Novel filtering steps were implemented to minimize false positives in the clinical setting. The algorithm was comprehensively validated using high-depth sequencing data from cancer cell lines and clinical samples and genome sequencing data from NA12878. JuLI showed improved performance mainly in positive predictive value over state-of-the-art fusion callers in cases with high-depth clinical sequencing and rescued a driver fusion from false negative in plasma cell-free DNA using joint calling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Cell Line, Tumor
  • Chromosome Breakpoints*
  • Clinical Decision-Making
  • Computational Biology / methods
  • DNA Damage
  • Genetic Testing* / methods
  • Genetic Testing* / standards
  • Genomics / methods
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Immunohistochemistry / methods
  • Medical Oncology* / methods
  • Medical Oncology* / standards
  • Neoplasms / diagnosis*
  • Neoplasms / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Polymerase Chain Reaction
  • Precision Medicine* / methods
  • Precision Medicine* / standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Workflow

Substances

  • Oncogene Proteins, Fusion